Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
355.41
-1.72 (-0.48%)
May 28, 2026, 11:57 AM EDT - Market open

PRAX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
536.33357.33215.3781.361.62138.7
Short-Term Investments
250.53242177.2-38.87137.21
Cash & Short-Term Investments
786.87599.33392.5781.3100.49275.91
Cash Growth
139.90%52.67%382.86%-19.10%-63.58%-6.98%
Other Current Assets
10.9111.5811.813.5810.3511.5
Total Current Assets
797.77610.91404.3784.88110.84287.41
Net Property, Plant & Equipment
1.490.241.362.653.874.87
Long-Term Investments
660.94326.7676.96---
Other Long-Term Assets
--0.420.420.420.47
Total Assets
1,460937.91483.1187.95115.13292.75
Accounts Payable
31.1624.6312.535.8214.6710.78
Accrued Expenses
17.6535.0323.767.4215.8526.84
Current Portion of Leases
1.440.111.261.131.010.81
Unearned Revenue
---1.392.82-
Total Current Liabilities
50.2459.7737.5515.7534.3538.43
Long-Term Leases
--0.111.372.53.5
Other Long-Term Liabilities
---1.162.18-
Total Long-Term Liabilities
--0.112.534.683.5
Total Liabilities
50.2459.7737.6618.2839.0241.94
Common Stock
0.020.020.010.010.010.01
Additional Paid-in Capital
2,6442,0181,282723.58606.92567.6
Accumulated Other Comprehensive Income
-1.590.560.65--0.17-0.18
Retained Earnings
-1,233-1,140-836.74-653.92-530.64-316.62
Shareholders' Equity
1,410878.14445.4569.6776.11250.81
Total Liabilities & Equity
1,460937.91483.1187.95115.13292.75
Total Debt
1.440.111.372.53.54.31
Net Cash (Debt)
785.43599.22391.278.8196.99271.6
Net Cash Growth
31.08%53.18%396.41%-18.75%-64.29%-8.20%
Net Cash Per Share
32.1426.6321.8511.9531.5695.96
Book Value
1,410878.14445.4569.6776.11250.81
Book Value Per Share
57.7039.0224.8810.5624.7788.62
Tangible Book Value
1,410878.14445.4569.6776.11250.81
Tangible Book Value Per Share
57.7039.0224.8810.5624.7788.62
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q